|
GOSS
|
Gossamer Bio, Inc.
|
0.02%
|
US
|
NASDAQ
|
|
FHTX
|
Foghorn Therapeutics Inc.
|
0.02%
|
US
|
NASDAQ
|
|
CMPS
|
COMPASS Pathways Plc
|
0.02%
|
US
|
NASDAQ
|
|
BMEA
|
Biomea Fusion, Inc.
|
0.02%
|
US
|
NASDAQ
|
|
ANNX
|
Annexon, Inc.
|
0.02%
|
US
|
NASDAQ
|
|
AFMD
|
Affimed Therapeutics B.V.
|
0.02%
|
US
|
NASDAQ
|
|
ABSI
|
Absci Corporation
|
0.02%
|
US
|
NASDAQ
|
|
ABOS
|
Acumen Pharmaceuticals, Inc.
|
0.02%
|
US
|
NASDAQ
|
|
QSI
|
Quantum-Si
|
0.02%
|
US
|
NASDAQ
|
|
XERS
|
Xeris Pharmaceuticals, Inc.
|
0.01%
|
US
|
NASDAQ
|
|
IMRX
|
Immuneering Corporation
|
0.01%
|
US
|
NASDAQ
|
|
GRPH
|
Graphite Bio, Inc.
|
0.01%
|
US
|
NASDAQ
|
|
GRCL
|
Gracell Biotechnologies Inc.
|
0.01%
|
US
|
NASDAQ
|
|
EVLO
|
Evelo Biosciences, Inc.
|
0.01%
|
US
|
NASDAQ
|
|
EIGR
|
Eiger BioPharmaceuticals, Inc.
|
0.01%
|
US
|
NASDAQ
|
|
CNTA
|
Centessa Pharmaceuticals plc
|
0.01%
|
US
|
NASDAQ
|
|
TIL
|
Instil Bio, Inc.
|
0.01%
|
US
|
NASDAQ
|